RxDoctor Payments DataLook up a doctor →

Kenya Kidd

Medical · Seattle, WANPI 1881601045

Payments from drug & device makers

$6,596in general payments, 2019–2025

Across 329 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$711
  • Johnson & Johnson$694
  • Daiichi Sankyo Inc.$472
  • Novartis$444
  • Bristol Myers Squibb$438
  • AstraZeneca$346
  • plus $3K from 47 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck35$711
Johnson & Johnson(2 entities)31$694
Daiichi Sankyo Inc.23$472
Novartis24$444
Bristol Myers Squibb20$438
AstraZeneca(2 entities)20$346
Incyte Corporation18$343
Eisai Inc.16$285
Lilly USA, LLC10$210
Sanofi10$202
Exelixis Inc.10$194
Regeneron Healthcare Solutions, Inc.8$187
Amgen11$185
Pfizer8$145
Pharmacosmos Therapeutics Inc.6$132
AVEO Pharmaceuticals, Inc.2$101
Seagen Inc.5$87
Bayer4$86
Sanofi-aventis U.S. LLC1$84
Ipsen Biopharmaceuticals, Inc4$79
E.r. Squibb & Sons, L.L.C.4$71
GSK4$69
Pharmaessentia USA Corporation3$67
Genentech USA, Inc.4$66
Novocure Inc.2$63
Tersera Therapeutics LLC2$61
Genmab U.S., Inc.3$59
Takeda Pharmaceuticals U.S.A., Inc.3$59
Beigene USA, Inc.4$53
Morphosys, US Inc.3$48
Apellis Pharmaceuticals, Inc.3$47
Stemline Therapeutics Inc.2$42
Puma Biotechnology, Inc.2$42
Coherus Oncology, Inc.2$42
AbbVie2$41
Sobi, Inc2$39
G1 Therapeutics, Inc.2$31
Boehringer Ingelheim1$31
Beone Medicines USA, Inc.1$23
Argenx US, Inc.1$20
ADC Therapeutics America, Inc.1$18
Taiho Oncology, Inc.1$18
Progenics Pharmaceuticals, Inc.1$17
Invivyd Inc1$16
Spectrum Pharmaceuticals Inc.1$16
Mylan Institutional Inc.1$15
Caris MPI, Inc.1$15
Sun Pharmaceutical Industries Inc.1$14
Astellas Pharma US Inc1$14
Karyopharm Therapeutics Inc.1$14
EMD Serono, Inc.1$13
AMAG Pharmaceuticals, Inc.1$12
Myriad Genetic Laboratories, Inc.1$12

How this compares

$6,596 in reported general payments places this provider in the 90th percentile of 457 medical providers in Washington.

See all medical providers in Washington →

Medicare billing

Part B allowed, 2024
$17,664
Medicare patients
132
Services billed
228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →